BIO is the world’s largest advocacy association representing member companies, state biotechnology groups, academic and research institutions, and related organizations across the United States and in 30+ countries.
Join our global community of member companies encouraging investment and promoting policies that support biotech innovation
BIO is proud to host a portfolio of partnering conferences that not only unite and empower biotech innovators and their ecosystem to improve lives but also offer a broad and unbiased venue to seek investment and BD&L opportunities
After almost two years virtual, BIO is bringing together the ag and environment biotech industry in-person from September 19-21, 2022 in Omaha, Nebraska! BIO Impact brings together biotech leaders working to address today's global challenges.
BIO’s partnering system attracts attendees because it’s both easy to use and increases the depth and breadth of meaningful connections made at your event.
Become an advocate for biotechnology and help shape policy that promotes innovation! Contact policymakers directly through BIO’s easy-to-use tool and have your voice heard.
Do you have questions about COVID-19 vaccines? We have your answers.
Being a member of BIO gives our company a collective voice and a seat at the table to drive meaningful and impactful change within an industry to which we are all tirelessly committed.
BIO has taken an active role in terms of promoting international collaboration and cross-border activities.
Having BIO in place to provide the leadership and advocacy that’s needed to make sure our innovation can get to patients as efficiently as possible is incomparable.
BIO’s committees have given us a chance to be involved with other leaders on the cutting edge of biotech. We share a common goal to advance science and technology in the bioeconomy.
They are not the household names, but the medications they are researching and developing could be the lifeline patients are waiting for. Today we explore how drug price controls—now making their way through Congress—could have unintended consequences for the small biotechs that are the engine of the drug development ecosystem. And even worse, for the patients who need them most.
Hosted by Dr. Michelle McMurry-Heath.
For more than a year now, COVID has been society’s focus—and rightly so. But today we turn our attention to another virus—HIV. After 40 years, there is still no cure or a vaccine for the disease. In this episode, we hear from Dr. Anthony Fauci and CEO of innovative company American Gene Technologies, Jeff Galvin, about the past, present, and future of HIV treatments and medications. Is there a cure on the horizon?
Hosted by Dr. Michelle McMurry-Heath.
Diverse STEM LinkedIn Community
The Forum for Diversity in Biotech & STEM connects top diverse STEM talent with employers to help them succeed in biotechnology.
Broaden your network by connecting and interacting with leaders from top biotech companies.
Expand your career horizons by viewing job listings.
Connect with other professionals in biotech and expand your knowledge and skills.
Watch I Am BIO Videos
The COVID-19 pandemic has shown the world the importance of science and biotech breakthroughs— biotechnology innovation is leading the charge to get the world back on track. Meet the people behind these breakthroughs, from scientists in the labs, to inspiring patients and patient advocates, to the young people who are the next generation of biotech leaders.
BIO Double Helix Sponsors
